Treatment of deep venous thrombosis at home: From theory to medical practice;Traitement des thromboses veineuses profondes à domicile: De l'évolution des idées à la pratique médicale

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 1, 1998, Pages 101-115

  Boccalon, Henri ^a,b   Elias, Antoine ^a,b   Chalé, Jean Jacques ^a,b   Cadene, Agnès ^a,b   Dumoulin, Anne ^a,b  

^a CHU RANGUEIL   (France)

^b Laboratoire d'anatomie Toulouse Purpan   (France)

Author keywords

Ambulatory care; France; Hemorrage; Heparin, low molecular weight; Thrombophlebitis

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; FEMALE; FRANCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOPHLEBITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; FEMALE; FRANCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; THROMBOPHLEBITIS;

EID: 0031603989     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. LEVINE M., GENT M., HIRSH J. et al. - A comparison of LMWH administered primarly at home with unfractionned heparin administered in the hospital for proximal DVT. N. Engl. J. Med., 1996, 334, 677-681.
2. KOOPMAN M.M., PRANDONI P., PIOVELLA F. et al. - Treatment of venous thrombosis with I.V. unfractionnated heparin administered in the hospitals as compared with subcutaneous LMWH administered at home. N. Engl. J. Med, 1996, 334, 682-687.
3. BLÄTTLER W. - Traitement à domicile des thromboses veineuses profondes. Sang Thrombose et Vaisseaux, 1997, 9, 315-319.
4. WELLS PS. - Accuracy of clinical assessment of deep vein thrombosis. Lancet, 1995, 345, 1326-1330.
5. LENSING A.W., PRINS M.H., DAVIDSON B.L., HIRSH J. - Treatment of deep venous thrombosis with LMWH : a meta analysis - Arch. Intern. Med. , 1995, 155, 601-607.
6. PALARETTI G. - Bleeding complications of oral anticoagulant treatment : an inception-cohort, prospective collaborative study (ISCOAT, University of Bologne, Italy). Lancet, 1996, 348, 423-429.
7. HIRSH J. - The optimal duration of anticoagulant therapy for venous thrombosis (editorial). N. Engl. J. Med. , 1995, 332, 1710-1711.
8. LEVINE M.N. et al. - Optimal duration of oral anticoagulant therapy : a randomized trial comparing four weeks with three months of warfarine in patients with proximal DVT. Thromb. Haemost., 1995, 74, 2, 606-611.
9. PINEDE L. et al. - Traitement anticoagulant pour MTEV : durée optimale de prescription des AVK : revue de la littérature. Pres. Med. , 1994, 23, 1817-1820.
10. RESEARCH COMMITTEE OF THE BRITISH THORACIC SOCIETY. Optimal duration of anticoagulation for DVT and pulmonary embolism. Lancet, 1992, 340, 873-876.
11. SCHULMAN S. et al. - A comparison of 6 weeks and 6 months of oral anticoagulant therapy after a first episode of the venous thromboembolism. N. Engl. J. Med, 1995, 332, 1662-1665.